Literature DB >> 24836826

Long-term maternal morbidity and mortality associated with ischemic placental disease.

Tracy Adams1, Corinne Yeh1, Nadia Bennett-Kunzier1, Wendy L Kinzler2.   

Abstract

Ischemic placental disease can have long-term maternal health implications. In this article, we discuss the three conditions of ischemic placental disease (preeclampsia, fetal growth restriction, and abruption placenta) and its associated long-term maternal morbidity. Retrospective observational studies comparing pregnancies complicated by ischemic placental disease to uncomplicated pregnancies suggest an increased long-term risk of hypertension, cardiovascular death, metabolic syndrome, and cerebrovascular disease. This association is much stronger in women who had an indicated-preterm delivery due to ischemic placental disease. It is important to adequately counsel women who are diagnosed with these conditions about their future health risks. Increased awareness of the potential health risks and multidisciplinary collaboration remains paramount to instituting the appropriate screening and preventative strategies (i.e., behavior modification) for affected women.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fetal growth restriction; Ischemic placental disease; Long term maternal morbidity; Placental abruption; Preeclampsia

Mesh:

Year:  2014        PMID: 24836826     DOI: 10.1053/j.semperi.2014.03.003

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  11 in total

1.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

2.  Genomic Alterations Are Enhanced in Placentas from Pregnancies with Fetal Growth Restriction and Preeclampsia: Preliminary Results.

Authors:  Tal Biron-Shental; Reuven Sharony; Atalia Shtorch-Asor; Meirav Keiser; Dana Sadeh-Mestechkin; Ido Laish; Aliza Amiel
Journal:  Mol Syndromol       Date:  2016-01-27

3.  Indicators of fetal growth and adult liver enzymes: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study.

Authors:  E W Harville; W Chen; L Bazzano; M Oikonen; N Hutri-Kähönen; O Raitakari
Journal:  J Dev Orig Health Dis       Date:  2016-12-06       Impact factor: 2.401

4.  Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.

Authors:  Eleftheria Lefkou; Apostolos Mamopoulos; Themistoklis Dagklis; Christos Vosnakis; David Rousso; Guillermina Girardi
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

5.  ELABELA plasma concentrations are increased in women with late-onset preeclampsia.

Authors:  Bogdan Panaitescu; Roberto Romero; Nardhy Gomez-Lopez; Percy Pacora; Offer Erez; Felipe Vadillo-Ortega; Lami Yeo; Sonia S Hassan; Chaur-Dong Hsu
Journal:  J Matern Fetal Neonatal Med       Date:  2018-07-22

6.  Cell-free DNA Methylation and Transcriptomic Signature Prediction of Pregnancies with Adverse Outcomes.

Authors:  Giorgia Del Vecchio; Qingjiao Li; Wenyuan Li; Shanthie Thamotharan; Anela Tosevska; Marco Morselli; Kyunghyun Sung; Carla Janzen; Xianghong Zhou; Matteo Pellegrini; Sherin U Devaskar
Journal:  Epigenetics       Date:  2020-10-13       Impact factor: 4.528

7.  Dynamic modeling of uteroplacental blood flow in IUGR indicates vortices and elevated pressure in the intervillous space - a pilot study.

Authors:  Christian J Roth; Eva Haeussner; Tanja Ruebelmann; Franz V Koch; Christoph Schmitz; Hans-Georg Frank; Wolfgang A Wall
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

8.  The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.

Authors:  Offer Erez; Roberto Romero; Eli Maymon; Piya Chaemsaithong; Bogdan Done; Percy Pacora; Bogdan Panaitescu; Tinnakorn Chaiworapongsa; Sonia S Hassan; Adi L Tarca
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

9.  Placental Microarray Profiling Reveals Common mRNA and lncRNA Expression Patterns in Preeclampsia and Intrauterine Growth Restriction.

Authors:  Diana Medina-Bastidas; Mario Guzmán-Huerta; Hector Borboa-Olivares; César Ruiz-Cruz; Sandra Parra-Hernández; Arturo Flores-Pliego; Ivan Salido-Guadarrama; Lisbeth Camargo-Marín; Eliakym Arambula-Meraz; Guadalupe Estrada-Gutierrez
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

10.  Prior pregnancy complications and maternal cardiovascular disease in young Korean women within 10 years after pregnancy.

Authors:  Geum Joon Cho; Ji Soo Um; Sa Jin Kim; Sung Won Han; Soo Bin Lee; Min-Jeong Oh; Jae Eun Shin
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-21       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.